Variant report
Variant | nsv981554 |
---|---|
Chromosome Location | chr7:98857837-98859015 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAX | chr7:98858922-98859026 | HepG2 | liver: | n/a | chr7:98858965-98858975 chr7:98858966-98858976 |
2 | MYC | chr7:98857709-98857865 | GM12878 | blood: | n/a | n/a |
3 | POLR2A | chr7:98858108-98858307 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr7:98858856-98859213 | K562 | blood: | n/a | n/a |
5 | POLR2A | chr7:98857804-98857999 | K562 | blood: | n/a | n/a |
6 | RCOR1 | chr7:98858194-98858248 | HepG2 | liver: | n/a | n/a |
7 | RCOR1 | chr7:98858051-98858324 | K562 | blood: | n/a | n/a |
8 | RCOR1 | chr7:98858046-98858390 | K562 | blood: | n/a | n/a |
9 | SPI1 | chr7:98858681-98858835 | K562 | blood: | n/a | chr7:98858740-98858753 chr7:98858742-98858751 chr7:98858741-98858754 |
10 | SPI1 | chr7:98858654-98858964 | HL-60 | blood: | n/a | chr7:98858740-98858753 chr7:98858742-98858751 chr7:98858741-98858754 |
11 | TBP | chr7:98858119-98858286 | K562 | blood: | n/a | n/a |
12 | USF1 | chr7:98858890-98859036 | HepG2 | liver: | n/a | n/a |
13 | ZNF143 | chr7:98858072-98858395 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MYH16 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191989513 | chr7:98857848-98857849 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs567085949 | chr7:98857861-98857862 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs527978463 | chr7:98857874-98857875 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs61742332 | chr7:98857884-98857885 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs567799705 | chr7:98857897-98857898 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs142091146 | chr7:98857898-98857899 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs557058827 | chr7:98857905-98857906 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs182608295 | chr7:98857958-98857959 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs539465176 | chr7:98857979-98857980 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs7792178 | chr7:98857986-98857987 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs10278443 | chr7:98857995-98857996 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs146326753 | chr7:98858013-98858014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs118040183 | chr7:98858074-98858075 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs114631762 | chr7:98858075-98858076 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs57260955 | chr7:98858100-98858101 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs562672060 | chr7:98858161-98858162 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs11769698 | chr7:98858167-98858168 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs138441973 | chr7:98858201-98858202 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs547351809 | chr7:98858209-98858210 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs560536387 | chr7:98858237-98858238 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs186810793 | chr7:98858259-98858260 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs142974223 | chr7:98858322-98858323 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs207468331 | chr7:98858335-98858336 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs561481785 | chr7:98858408-98858409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144323334 | chr7:98858416-98858417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191632620 | chr7:98858444-98858445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569004223 | chr7:98858504-98858505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571225558 | chr7:98858507-98858508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182641976 | chr7:98858513-98858514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551510024 | chr7:98858552-98858553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551134921 | chr7:98858559-98858560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187099242 | chr7:98858614-98858615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533861482 | chr7:98858639-98858640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555611573 | chr7:98858668-98858669 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs148797984 | chr7:98858698-98858699 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs370230570 | chr7:98858709-98858710 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs368622844 | chr7:98858719-98858720 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs550601669 | chr7:98858740-98858741 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs12535654 | chr7:98858784-98858785 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs6964174 | chr7:98858811-98858812 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs545438706 | chr7:98858816-98858817 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs560294936 | chr7:98858854-98858855 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs572370083 | chr7:98858897-98858898 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs542971926 | chr7:98858971-98858972 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164920 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 16608533 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Liver carcinoma | 19366792 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Breast cancer | 21858162 | CNVD |
Emphysema | 19352772 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 19401682 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:98853400-98859000 | Weak transcription | Esophagus | oesophagus |
2 | chr7:98853400-98864600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr7:98853600-98863200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr7:98853600-98864400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr7:98857200-98860000 | Weak transcription | Right Atrium | heart |
6 | chr7:98857800-98858200 | Enhancers | Pancreas | Pancrea |
7 | chr7:98858200-98858600 | Weak transcription | Pancreas | Pancrea |
8 | chr7:98858600-98860200 | Enhancers | Pancreas | Pancrea |
9 | chr7:98858800-98859600 | Enhancers | Stomach Mucosa | stomach |
10 | chr7:98859000-98859200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr7:98859000-98859600 | Enhancers | Esophagus | oesophagus |